Active ingredients
Pharmacological Group
Used in the treatment
- R60.0 Localized oedema
- R58 Haemorrhage, not elsewhere classified
- R29.0 Tetany
- R25.2 Cramp and spasm
- R09.1 Pleurisy
- R04.8 Haemorrhage from other sites in respiratory passages
- R04.0 Epistaxis
- O62.2 Other uterine inertia
- O25 Malnutrition in pregnancy
- O15 Eclampsia
- N95.1 Menopausal and female climacteric states
- N93 Other abnormal uterine and vaginal bleeding
- N71 Inflammatory disease of uterus, except cervix
- N70 Salpingitis and oophoritis
- N05 Unspecified nephritic syndrome
- M83.9 Adult osteomalacia, unspecified
- L50 Urticaria
- L40 Psoriasis
- L30.9 Dermatitis, unspecified
- L29 Pruritus
- K92.2 Gastrointestinal haemorrhage, unspecified
- K75.8 Other specified inflammatory liver diseases
- K71 Toxic liver disease
- J45 Asthma
- J18 Pneumonia, organism unspecified
- I78.8 Other diseases of capillaries
- I77.6 Arteritis, unspecified
- G83.8 Other specified paralytic syndromes
- E83.5.1* Hypocalcemia
- E83.5 Disorders of calcium metabolism
- E58 Dietary calcium deficiency
- E55.0 Rickets, active
- E20 Hypoparathyroidism
- A16.2 Tuberculosis of lung, without mention of bacteriological or histological confirmation
- T56.0 Toxic effect, lead and its compounds
- T56.8 Toxic effect, other metals
- T65.8 Toxic effect, toxic effect of other specified substances
- T66 Unspecified effects of radiation
- T78.3 Angioneurotic oedema
- T78.4 Allergy, unspecified
- T80.6 Other serum reactions
- Z39.1 Care and examination of lactating mother